-
Mashup Score: 1Patiromer Treatment in Patients With CKD, Hyperkalemia, and Hyperphosphatemia: A Post Hoc Analysis of 3 Clinical Trials - 1 year(s) ago
Patients with chronic kidney disease (CKD), hyperkalemia (serum potassium [sK+] >5.0 mEq/L), and hyperphosphatemia experience poor clinical outcomes. Patiromer, a potassium binder that uses calcium as the exchange ion, may also reduce sP. We characterized the effect of patiromer on serum phosphorous (sP) in patients with CKD, hyperkalemia, and hyperphosphatemia.
Categories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 2Potassium Binders for Patients With Heart Failure? The Real Enlightenment of the DIAMOND Trial - 2 year(s) ago
Milton Packer, M.D; Potassium Binders for Patients With Heart Failure? The Real Enlightenment of the DIAMOND Trial, European Heart Journal, , ehac399, https://d
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet-
The terror of hyperkalemia and the advent of new potassium binders: look at #EHJ Editorial on these new drugs in heart failure! #cardiotwitter #ehj #potassium #binders #heart #failure #patiromer #spironolactone #eplerenone @ESC_Journals @escardio https://t.co/9eoJwdqiB5 https://t.co/G3oTahRVtW
-
-
Mashup Score: 0Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial | Oxford Academic - 2 year(s) ago
This PDF is available to Subscribers Only View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription. Close
Source: academic.oup.comCategories: Cardiologists, Latest HeadlinesTweet-
The impact of Patiromer in patients with heart failure and reduced ejection fraction: #EHJ news from the DIAMOND trial! #Heart #failure #renin-angiotensin #aldosterone #inhibitors# hyperkalemia #patiromer #cardiotwitter #ehj @ESC_Journals @escardio https://t.co/RjW4qOaEOG https://t.co/UUUfIBOall
-
-
Mashup Score: 2Potassium Binders for Patients With Heart Failure? The Real Enlightenment of the DIAMOND Trial - 2 year(s) ago
Milton Packer, M.D; Potassium Binders for Patients With Heart Failure? The Real Enlightenment of the DIAMOND Trial, European Heart Journal, , ehac399, https://d
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet-
This insightful editorial comment by #MiltonPacker 👇🏻 #Potassium Binders for Patients With #HeartFailure? The Real Enlightenment of the #DIAMOND Trial #CardioTwitter #MRAs #Patiromer https://t.co/5EnU7rJISt @ESC_Journals @escardio @JavedButler1 @hvanspall @AndrewJSauer https://t.co/D4HAx0BRgV
-
-
Mashup Score: 0Potassium Binders for Patients With Heart Failure? The Real Enlightenment of the DIAMOND Trial - 2 year(s) ago
Milton Packer, M.D; Potassium Binders for Patients With Heart Failure? The Real Enlightenment of the DIAMOND Trial, European Heart Journal, , ehac399, https://d
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet-
Potassium Binders for Patients With Heart Failure? The Real Enlightenment of the DIAMOND Trial! https://t.co/9eoJwdqiB5 #HFrEF #MRA #patiromer #cardiotwitter @escardio @ESC_Journals https://t.co/teEQgQqo2j
-
-
Mashup Score: 16Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial - 2 year(s) ago
AbstractAims. To investigate the impact of patiromer on serum potassium level and its ability to enable specified target doses of renin-angiotensin-aldosterone
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet-
Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial. https://t.co/3JFLLdHDrJ #HFrEF #RAASi #hyperkalemia #patiromer #cardiotwitter @escardio @ESC_Journals https://t.co/a1S4vRlBqj
-
-
Mashup Score: 1
WASHINGTON — In this Healio video exclusive, Javed Butler, MD, MPH, MBA, FACC, FAHA, FESC, discusses the results of the DIAMOND trial of patiromer for the reduction of hyperkalemia in patients with HF with reduced ejection fraction.Butler, Cardiology Today Editorial Board Member, president of the Baylor Scott and White Research Institute, senior vice president for Baylor Scott and White
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
In this Healio video exclusive, Javed Butler, MD, MPH, MBA, FACC, FAHA, FESC, discusses the results of the DIAMOND trial of #patiromer for the reduction of hyperkalemia in patients with #HFrEF @UMMCnews @ACCinTouch #ACC22 #ACCNews #Cardiotwitter https://t.co/S4NrlaFSCM
-
#Patiromer in Patients With CKD, Hyperkalemia, and Hyperphosphatemia: A Post Hoc Analysis of 3 Clinical Trials https://t.co/Tu7e5rOpgn